z-logo
open-access-imgOpen Access
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease
Author(s) -
J. Antonio Gutierrez,
Hillary Mulder,
W. Schuyler Jones,
Frank W. Rockhold,
Iris Baumgärtner,
Jeffrey S. Berger,
Juuso Blomster,
F. Gerry R. Fowkes,
Peter Held,
Brian G. Katona,
Kenneth W. Mahaffey,
Lars Norgren,
William R. Hiatt,
Manesh R. Patel
Publication year - 2018
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2018.5239
Subject(s) - medicine , ticagrelor , stroke (engine) , myocardial infarction , cardiology , coronary artery disease , clinical endpoint , interquartile range , clopidogrel , randomized controlled trial , mechanical engineering , engineering
Compared with patients with PAD alone, the risk of major adverse cardiac events and lower-extremity revascularization increased with multiple vascular bed involvement. There was no clear increased risk of bleeding associated with polyvascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom